Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 625.00 | 414.82 | 528.00 | 795.25 | 0.6639 | 0.2930 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 625.00 | 414.82 | 893.00 | 795.25 | 1.1229 | 1.2628 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 892.00 | 795.25 | 1.1217 | 1.2601 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 625.00 | 414.82 | 535.00 | 795.25 | 0.6727 | 0.3112 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 1037.00 | 795.25 | 1.3040 | 1.6534 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 990.00 | 795.25 | 1.2449 | 1.5255 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 625.00 | 414.82 | 588.00 | 795.25 | 0.7394 | 0.4500 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 441.00 | 795.25 | 0.5545 | 0.0674 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 625.00 | 414.82 | 792.00 | 795.25 | 0.9959 | 0.9913 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 815.00 | 795.25 | 1.0248 | 1.0529 | |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 625.00 | 414.82 | 834.00 | 795.25 | 1.0487 | 1.1040 |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 625.00 | 414.82 | 675.00 | 795.25 | 0.8488 | 0.6796 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 727.00 | 795.25 | 0.9142 | 0.8177 | |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 860.00 | 795.25 | 1.0814 | 1.1739 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 625.00 | 414.82 | 466.00 | 795.25 | 0.5860 | 0.1319 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 789.00 | 795.25 | 0.9921 | 0.9833 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 955.00 | 795.25 | 1.2009 | 1.4305 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 1181.00 | 795.25 | 1.4851 | 2.0475 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 625.00 | 414.82 | 915.00 | 795.25 | 1.1506 | 1.3223 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 625.00 | 414.82 | 501.00 | 795.25 | 0.6300 | 0.2227 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 760.00 | 795.25 | 0.9557 | 0.9057 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 625.00 | 414.82 | 918.00 | 795.25 | 1.1544 | 1.3304 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 988.00 | 795.25 | 1.2424 | 1.5201 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 625.00 | 414.82 | 1094.00 | 795.25 | 1.3757 | 1.8090 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 625.00 | 414.82 | 362.00 | 795.25 | 0.4552 | -0.1350 |